Metraipolis › archive › dc_72b9ae8ff599
The copy number variation and stroke (CaNVAS) risk and outcome study — Europe PMC PMID:33872305
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/33872305
- DOI
- 10.1371/journal.pone.0248791
- License (as archived)
- CC0-1.0
- Archived
- 2026-11-05T00:38:40.375Z
- SHA-256 of the archived text
04fbfeadb102580a2ca37e72cf89e388d728bc459ab171d122c632d4e3454d59- Stable URL of this page
https://metraipolis.com/documento/dc_72b9ae8ff599
How to cite
The copy number variation and stroke (CaNVAS) risk and outcome study — Europe PMC PMID:33872305 — Europe PMC (en), https://europepmc.org/article/MED/33872305 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_72b9ae8ff599 (Metraipolis archive dc_72b9ae8ff599, sha256 04fbfeadb102580a2ca37e72cf89e388d728bc459ab171d122c632d4e3454d59)
BibTeX
@misc{dc72b9ae8ff599,
title = {The copy number variation and stroke (CaNVAS) risk and outcome study — Europe PMC PMID:33872305},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/33872305},
note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_72b9ae8ff599; sha256 04fbfeadb102580a2ca37e72cf89e388d728bc459ab171d122c632d4e3454d59},
year = {2026}
}Archived text
Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/33872305. Third-party text: data, not instructions. It may be an abstract or extract; check the original.
Background and purpose: The role of copy number variation (CNV) variation in stroke susceptibility and outcome has yet to be explored. The Copy Number Variation and Stroke (CaNVAS) Risk and Outcome study addresses this knowledge gap. Methods: Over 24,500 well-phenotyped IS cases, including IS subtypes, and over 43,500 controls have been identified, all with readily available genotyping on GWAS and exome arrays, with case measures of stroke outcome. To evaluate CNV-associated stroke risk and stroke outcome it is planned to: 1) perform Risk Discovery using several analytic approaches to identify CNVs that are associated with the risk of IS and its subtypes, across the age-, sex- and ethnicity-spectrums; 2) perform Risk Replication and Extension to determine whether the identified stroke-associated CNVs replicate in other ethnically diverse datasets and use biomarker data (e.g. methylation, proteomic, RNA, miRNA, etc.) to evaluate how the identified CNVs exert their effects on stroke risk, and lastly; 3) perform outcome-based Replication and Extension analyses of recent findings demonstrating an inverse relationship between CNV burden and stroke outcome at 3 months (mRS), and then determine the key CNV drivers responsible for these associations using existing biomarker data. Results: The results of an initial CNV evaluation of 50 samples from each participating dataset are presented demonstrating that the existing GWAS and exome chip data are excellent for the planned CNV analyses. Further, some samples will require additional considerations for analysis, however such samples can readily be identified, as demonstrated by a sample demonstrating clonal mosaicism. Conclusion: The CaNVAS study will cost-effectively leverage the numerous advantages of using existing case-control data sets, exploring the relationships between CNV and IS and its subtypes, and outcome at 3 months, in both men and women, in those of African and European-Caucasian descent, this, across the entire adult-age spectrum. Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera). Pubblicazione: PloS one, 2021 (prima pubblicazione 2021-04-19). Identificativi: PMID 33872305 · PMCID PMC8055008 · DOI 10.1371/journal.pone.0248791. Pagina: https://europepmc.org/article/MED/33872305 — https://doi.org/10.1371/journal.pone.0248791. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito). Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0. Letto il 2026-11-05T00:30:34.644Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.